110586 ⎘
ssDNA viruses; Details; Parvoviridae; Parvovirus, e.g. minute virus of mice; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
cis AND trans REQUIREMENTS FOR TERMINAL RESOLUTION OF HUMAN BOCAVIRUS 1
#2RNA AND DNA BASE EDITING VIA ENGINEERED ADAR RECRUITMENT
#3NUCLEIC ACID MOLECULES AND USES THEREOF FOR NON-VIRAL GENE THERAPY
#4ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING INCREASED HEART ENRICHMENT
#5CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIONS
#6BACULOVIRUS EXPRESSION SYSTEM
#7H-1 PV EXPRESSING RNAi EFFECTORS
#8VECTOR, LINEAR COVALENTLY CLOSED DNA PRODUCTION METHOD USING VECTOR, PARVOVIRUS VECTOR PRODUCTION METHOD, AND PARVOVIRUS-VECTOR-PRODUCING CELL PRODUCTION METHOD
#9CANINE PARVOVIRUS (CPV) NANOBODY CPV-VHH-H1 AND USE THEREOF
#10CLOSED-END DNA PRODUCTION WITH INVERTED TERMINAL REPEAT SEQUENCES
#11ENGINEERED TARGET SPECIFIC NUCLEASES
#12Vectors for Liver-Directed Gene Therapy of Hemophilia and Methods and Use Thereof
#13GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING TRANSTHYRETIN (TTR) AND USES THEREOF
#14ENGINEERED ITR SEQUENCES AND METHODS OF USE
#15VIRAL VECTOR COMBINING GENE THERAPY AND GENOME EDITING APPROACHES FOR GENE THERAPY OF GENETIC DISORDERS
#16RNA AND DNA BASE EDITING VIA ENGINEERED ADAR RECRUITMENT
#17H-1 PV EXPRESSING RNAI EFFECTORS TARGETING CDK9
#18CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIONS
#19NUCLEIC ACID MOLECULES AND USES THEREOF FOR NON-VIRAL GENE THERAPY
#20Engineered target specific nucleases
#21Vectors for liver-directed gene therapy of hemophilia and methods and use thereof
#22cis and trans requirements for terminal resolution of human bocavirus 1
#23Method for Treating Melanoma Using a Herpes Simplex Virus and an Immune Checkpoint Inhibitor
#24TISSUE SELECTIVE TRANSGENE EXPRESSION
#25Tissue selective transgene expression
#26Tissue selective transgene expression
#27Tissue selective transgene expression
#28Modified CRISPR RNA and modified single CRISPR RNA and uses thereof
#29Viral vectors for the treatment of retinal dystrophy
#30Optimized liver-specific expression systems for FVIII and FIX
#31Treatment of amyotrophic lateral sclerosis
#32Adenovirus derived helper virus for enhancing recombinant parvovirus production
#33Delivery of a therapeutic agent to the cerebral cortex by administering a viral vector by convection enhanced diffusion into the white matter of the brain
#34Viral vectors for the treatment of retinal dystrophy
#35Retinal OFF circuit-specific promoter
#36Vectors for liver-directed gene therapy of hemophilia and methods and use thereof
#37Method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor
#38Modified parvovirus useful for gene silencing
#39Polypeptides and vectors for targeting HER2/expressing cells and uses thereof
#40Viral vectors for the treatment of retinal dystrophy
#41Live attenuated parvovirus
#42Modified parvovirus having enhanced anti-tumor efficacy
#43Modified rodent parvovirus capable of propagating and spreading through human gliomas
#44USE OF RECOMBINANT ANTIGENS TO DETERMINE THE IMMUNE STATUS OF AN ANIMAL